DRK Kliniken Berlin Westend

Berlin, Germany
General hospital in Berlin
Spandauer Damm 130, 14050 Berlin

About DRK Kliniken Berlin Westend


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Celgene
5
Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)
3
Hoffmann-La Roche
3
Actelion
2
Takeda
2
co.don AG
2
Amgen
1
Boehringer Ingelheim
1
Daiichi Sankyo, Inc.
1
Diamyd Therapeutics AB
1
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
1
Total Rows: 21

Clinical Trials at DRK Kliniken Berlin Westend


During the past decade, DRK Kliniken Berlin Westend conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 9 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years66551111112244220000001122114411Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial
2004-01-01
2006-06-01
Terminated
1,050
CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction
2006-10-01
2010-01-01
Completed
337
A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)
2008-07-01
2011-08-01
Terminated
334
Efficacy and Safety Study of co.Don Chondrosphere to Treat Cartilage Defects
2010-10-01
2020-02-01
Completed
102
Assessment of Efficacy and Safety of 3 Different Doses of co.Don Chondrosphere to Treat Large Cartilage Defects
2010-10-01
2018-03-01
Completed
75
Safety and Efficacy With NOVOCART® Disc Plus (ADCT) for the Treatment of Degenerative Disc Disease in Lumbar Spine
2012-08-01
2021-06-14
Completed
120
Effects of Oral Sildenafil on Mortality in Adults With PAH
2014-09-22
2021-02-26
Terminated
385
A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors
2014-05-21
2020-04-16
Completed
609

Rows per page:

1–32 of 32

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "DRK Kliniken Berlin Westend" #1 sponsor was "Celgene" with 5 trials, followed by "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Actelion" with 2 trials sponsored and "Takeda" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "DRK Kliniken Berlin Westend" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Centre Hospitalier Universitaire de Besancon" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator, "Ferrer Internacional S.A." with 1 trials as a collaborator and "General University Hospital, Prague" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCelgene: 5Celgene: 5Acceleron Pharma Inc.(a wholly ownedsubsidiary of MerckSharp and Dohme, asubsidiary of Merck &Co., Inc.): 3Acceleron Pharma Inc.(a wholly ownedsubsidiary of MerckSharp and Dohme, asubsidiary of Merck &Co., Inc.): 3Hoffmann-La Roche: 3Hoffmann-La Roche: 3Actelion: 2Actelion: 2Takeda: 2Takeda: 2co.don AG: 2co.don AG: 2Amgen: 1Amgen: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1Diamyd Therapeutics AB: 1Diamyd Therapeutics AB: 1

Created with Highcharts 11.1.0Top CollaboratorsBristol-Myers Squibb: 1Bristol-Myers Squibb: 1Centre HospitalierUniversitaire deBesancon: 1Centre HospitalierUniversitaire deBesancon: 1Charite University,Berlin, Germany: 1Charite University,Berlin, Germany: 1Ferrer Internacional S.A.: 1Ferrer Internacional S.A.: 1General UniversityHospital, Prague: 1General UniversityHospital, Prague: 1ICON plc: 1ICON plc: 1Istituto Di RicercheFarmacologiche MarioNegri: 1Istituto Di RicercheFarmacologiche MarioNegri: 1London School ofHygiene and TropicalMedicine: 1London School ofHygiene and TropicalMedicine: 1Medidata Solutions: 1Medidata Solutions: 1OMT GmbH & Co. KG: 1OMT GmbH & Co. KG: 1

Clinical Trials Conditions at DRK Kliniken Berlin Westend


According to Clinical.Site data, the most researched conditions in "DRK Kliniken Berlin Westend" are "Pulmonary Arterial Hypertension" (7 trials), "Ulcerative Colitis" (6 trials), "Crohn Disease" (3 trials), "Crohn's Disease" (3 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "DRK Kliniken Berlin Westend" in a lesser frequency.

Clinical Trials Intervention Types at DRK Kliniken Berlin Westend


Most popular intervention types in "DRK Kliniken Berlin Westend" are "Drug" (29 trials), "Device" (3 trials), "Other" (3 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "GED-0301" (3 trials), "Sotatercept" (3 trials), "Etrolizumab" (2 trials) and "RPC1063" (2 trials). Other intervention names were less common.

Clinical Trials Genders at DRK Kliniken Berlin Westend


The vast majority of trials in "DRK Kliniken Berlin Westend" are 30 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at DRK Kliniken Berlin Westend


Currently, there are NaN active trials in "DRK Kliniken Berlin Westend". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in DRK Kliniken Berlin Westend, undefined suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in DRK Kliniken Berlin Westend, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 22Phase 3: 22Phase 2: 4Phase 2: 4Phase 4: 3Phase 4: 3Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 15Completed: 15Terminated: 7Terminated: 7Active, not recruiting: 5Active, not recruiting: 5Recruiting: 3Recruiting: 3Unknown status: 1Unknown status: 1Withdrawn: 1Withdrawn: 1